logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울행정법원 2018.06.08 2017구합71499
국가연구개발사업제재조치처분 취소청구의 소
Text

1. Disposition of restrictions on participation in national research and development projects conducted by the Defendant on July 3, 2017 and B University.

Reasons

1. Details of the disposition;

A. The Plaintiff is a professor of biotechnology and biotechnology in the previous disposition. The Korean Research Foundation (hereinafter “Korea Research Foundation”) is a foundation.

The Ministry of Science, ICT and Future Planning (Ministry of Science, ICT and Future Planning) was organized on July 26, 2017 by the Ministry of Science, ICT and Future Planning.

The Minister of Science, ICT and Future Planning and the Defendant (hereinafter referred to as “Defendant”).

Article 11(4) of the Framework Act on Science and Technology, the former Regulations on the Management of Research and Development Projects in Science and Technology under the jurisdiction of the Ministry of Science, ICT and Future Planning (amended by Ordinance of the Ministry of Science and ICT No. 3, Aug. 24, 2017; hereinafter “former Regulations on

(2) Around April 2009, the Korea Research Foundation entered into an agreement on standards for research and development tasks with respect to “C” (hereinafter “the instant research and development”) by setting the total research and development period from May 1, 2009 to February 28, 2014 with the Industry-Academic Cooperation Foundation and the supervising research officer as “Plaintiff”, respectively, as “C” (hereinafter “the instant research and development”).

3. An industry-academic cooperation foundation for the 3rd university has received the total of KRW 1,165,200,000 in accordance with the Convention on the Standards for Research and Development tasks.

The purpose of this study is to develop the RNA interference base that can treat the EN virus in the Z-9Rs by combining the CDA 7 ports that combine E business viruss with the Tcell, the main cell of the EN virus, and the Z-9R, but it is weak to reorganize the RNA model, standardize the transmission system, and treat EN viruss.

Theses, patents, and stages evaluation, which are the performance goals presented in the plan of this task, are very insufficient.

The quality level of research outcomes shall be compared to the plan.

arrow